Company Statement: Valeant Pharmaceuticals receives FTC clearance for Medicis acquisition
MLex Summary: Valeant Pharmaceuticals International announced today that the U.S. Federal Trade Commission has completed its review of the proposed acquisition of Medicis Pharmaceutical Corporation by Valeant and has granted early termination...To view the full article, register now.
Already a subscriber? Click here to view full article